Jens J. Holst

2.7k total papers · 158.9k total citations
1.9k papers, 118.8k citations indexed

About

Jens J. Holst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Jens J. Holst has authored 1.9k papers receiving a total of 118.8k indexed citations (citations by other indexed papers that have themselves been cited), including 1.2k papers in Endocrinology, Diabetes and Metabolism, 826 papers in Surgery and 551 papers in Physiology. Recurrent topics in Jens J. Holst's work include Diabetes Treatment and Management (903 papers), Pancreatic function and diabetes (531 papers) and Diet and metabolism studies (465 papers). Jens J. Holst is often cited by papers focused on Diabetes Treatment and Management (903 papers), Pancreatic function and diabetes (531 papers) and Diet and metabolism studies (465 papers). Jens J. Holst collaborates with scholars based in Denmark, United States and Germany. Jens J. Holst's co-authors include Carolyn F. Deacon, Sten Madsbad, Cathrine Ørskov, Michael A. Nauck, Tina Vilsbøll, Bolette Hartmann, Filip K. Knop, Thure Krarup, Arne Astrup and Bo Åhrén and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jens J. Holst

1.9k papers receiving 115.3k citations

Hit Papers

The Physiology of Glucago... 1987 2026 2000 2013 2007 2015 1993 1998 2002 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. The Physiology of Glucagon-like Peptide 1
    2007 2.5k citations Jens J. Holst Physiological Reviews profile →
  2. Type 2 diabetes mellitus
    2015 1.6k citations Leif Groop, Robert R. Henry et al. profile →
  3. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
    1993 1.3k citations Michael A. Nauck, Cathrine Ørskov et al. Journal of Clinical Investigation profile →
  4. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
    1998 1.1k citations Anne Flint, Anne Raben et al. Journal of Clinical Investigation profile →
  5. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
    2002 1.1k citations Mette Zander, Sten Madsbad et al. The Lancet profile →
  6. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
    1993 903 citations Michael A. Nauck, C. �rskov et al. Diabetologia profile →
  7. Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
    1994 764 citations Cathrine Ørskov, André Wettergren et al. Diabetes profile →
  8. Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus
    1992 724 citations M. Gutniak, Cathrine Ørskov et al. New England Journal of Medicine profile →
  9. Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
    2001 716 citations Tina Vilsbøll, Thure Krarup et al. Diabetes profile →
  10. Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
    2001 700 citations Sten Madsbad, Linda Hilsted et al. The Journal of Clinical Endocrinology & Metabolism profile →
  11. Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations
    2006 686 citations Ewan R. Pearson, Isabelle Flechtner et al. New England Journal of Medicine profile →
  12. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
    1997 675 citations Michael A. Nauck, Jens J. Holst et al. American Journal of Physiology-Endocrinology and Metabolism profile →
  13. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
    1995 655 citations Carolyn F. Deacon, Anders H. Johnsen et al. The Journal of Clinical Endocrinology & Metabolism profile →
  14. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
    1995 643 citations Carolyn F. Deacon, Michael A. Nauck et al. Diabetes profile →
  15. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
    2004 559 citations M. Gutniak, Jens J. Holst et al. American Journal of Physiology-Endocrinology and Metabolism profile →
  16. Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
    1993 541 citations A. Wettergren, Birgit Schjoldager et al. Digestive Diseases and Sciences profile →
  17. Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects
    1995 538 citations Carolyn F. Deacon, Michael A. Nauck et al. Diabetes profile →
  18. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem
    1997 537 citations Philip J. Larsen, Mads Tang‐Christensen et al. Neuroscience profile →
  19. Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
    1987 483 citations Jens J. Holst, Cathrine Ørskov et al. FEBS Letters profile →
  20. Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
    2009 451 citations Mary‐Elizabeth Patti, Sander M. Houten et al. Obesity profile →
  21. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
    2011 416 citations Jacob Lønborg, Niels Vejlstrup et al. European Heart Journal profile →
  22. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
    2020 305 citations M Gabe, Jens J. Holst et al. JCI Insight profile →
  23. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon
    2018 299 citations C. Christiansen, M Gabe et al. American Journal of Physiology-Gastrointestinal and Liver Physiology profile →
  24. Discovery, characterization, and clinical development of the glucagon-like peptides
    2017 292 citations Daniel J. Drucker, Jens J. Holst et al. Journal of Clinical Investigation profile →
  25. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
    2021 279 citations J. Lundgren, Charlotte Janus et al. New England Journal of Medicine profile →
  26. Insulin Secretion Depends on Intra-islet Glucagon Signaling
    2018 258 citations Berit Svendsen, Olav Larsen et al. Cell Reports profile →
  27. The expanding incretin universe: from basic biology to clinical translation
    2023 128 citations Daniel J. Drucker, Jens J. Holst Diabetologia profile →
  28. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial
    2024 97 citations Simon Birk Kjær Jensen, Martin Bæk Blond et al. EClinicalMedicine profile →
  29. Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment
    2024 48 citations Simon Birk Kjær Jensen, Rasmus Michael Sandsdal et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jens J. Holst 69.2k 48.5k 32.3k 29.6k 15.2k 1.9k 118.8k
Stephen R. Bloom 16.2k 0.2× 17.9k 0.4× 19.5k 0.6× 23.5k 0.8× 28.8k 1.9× 1.1k 79.8k
Daniel J. Drucker 36.2k 0.5× 24.1k 0.5× 20.3k 0.6× 9.7k 0.3× 6.3k 0.4× 425 59.1k
Gerald I. Shulman 24.3k 0.4× 19.7k 0.4× 49.6k 1.5× 44.8k 1.5× 6.9k 0.5× 619 106.4k
Bart Staels 13.1k 0.2× 17.0k 0.4× 41.4k 1.3× 18.2k 0.6× 5.1k 0.3× 789 78.6k
Kenji Kangawa 9.8k 0.1× 10.4k 0.2× 26.1k 0.8× 24.7k 0.8× 34.8k 2.3× 995 84.3k
Jeffrey S. Flier 12.5k 0.2× 9.1k 0.2× 22.6k 0.7× 28.4k 1.0× 25.4k 1.7× 314 80.6k
Johan Auwerx 8.0k 0.1× 12.8k 0.3× 51.2k 1.6× 29.9k 1.0× 5.3k 0.3× 638 96.2k
Jerrold M. Olefsky 15.5k 0.2× 12.4k 0.3× 34.6k 1.1× 24.9k 0.8× 4.6k 0.3× 592 71.7k
C. Ronald Kahn 13.9k 0.2× 14.4k 0.3× 36.9k 1.1× 26.6k 0.9× 5.5k 0.4× 515 74.6k
Frank J. Gonzalez 10.7k 0.2× 14.2k 0.3× 56.5k 1.7× 16.7k 0.6× 2.0k 0.1× 1.3k 118.9k

Countries citing papers authored by Jens J. Holst

Since Specialization
Citations

This map shows the geographic impact of Jens J. Holst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens J. Holst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens J. Holst more than expected).

Fields of papers citing papers by Jens J. Holst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens J. Holst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens J. Holst. The network helps show where Jens J. Holst may publish in the future.

Co-authorship network of co-authors of Jens J. Holst

This figure shows the co-authorship network connecting the top 25 collaborators of Jens J. Holst. A scholar is included among the top collaborators of Jens J. Holst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens J. Holst. Jens J. Holst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Lin Breakdown of academic impact, for papers by Matthew J. Budoff Breakdown of academic impact, for papers by Jeffrey L. Cummings Breakdown of academic impact, for papers by Bharat Bhushan Breakdown of academic impact, for papers by Stephen J. Lippard Breakdown of academic impact, for papers by Yu Chen Breakdown of academic impact, for papers by David L. Kaplan Breakdown of academic impact, for papers by Rattan Lal
Rankless by CCL
2026